Survival analysis shows that hypomethylation of ALDOA in glioma and ovarian cancer is associated with significantly worse overall survival (p < 0.001 in glioma, p = 0.0388 in ovarian cancer) (Fig. 3E). Here, ALDOA is linked to central nervous system cancer.